Pick up almost any prescription medicine in India and there's a letter on the label: H, H1, X, sometimes G. Pharmacists know what they mean for the sale. Packaging, regulatory and brand teams need to know what they mean for the label, the artwork and — increasingly — the barcode. And since 2023 there's a newer letter that works differently from all the others: Schedule H2.

This guide explains each schedule under the Drugs Rules, 1945 in plain terms, what each one requires on the pack and at the counter, and why a single product can now fall under two schedules at once.

H2 is not a sales category
Schedules G, H, H1 and X decide how a medicine may be sold. Schedule H2 decides what code it must carry. A product can be Schedule H1 for sale and Schedule H2 for labelling — and from 2027, many will be.

The Schedules at a Glance

Schedule What it covers What goes on the label What it means at the counter
Schedule G Drugs to be used under medical supervision A caution that the preparation is dangerous to take except under medical supervision No prescription requirement in the Schedule H sense
Schedule H Prescription drugs — the largest group The Rx symbol and a warning that it may be sold by retail only on the prescription of a Registered Medical Practitioner Sale only against a valid prescription
Schedule H1 Selected antibiotics, anti-TB drugs and certain habit-forming drugs (in force since March 2014) The Rx symbol in red, plus a boxed warning on the label Prescription required, and a separate register (prescriber, patient, drug and quantity) kept for three years
Schedule X Drugs with high potential for abuse, including certain psychotropics The XRx symbol in red, with the prescription-only warning Prescription in duplicate, one copy retained for two years, separate records and secure storage
Schedule H2 Table 1: 300 named brands (since 1 August 2023). Table 2: all vaccines, antimicrobials, anticancer and NDPS drugs (from 2027–28) A Bar Code or QR Code carrying the prescribed data set No change to how it is sold — the code is a traceability and authentication requirement

Schedule H: The Baseline for Prescription Medicines

Most prescription medicines in India are Schedule H. For the packaging team, the requirement is about the label: the Rx symbol and the prescription-only warning, in addition to the general labelling particulars every drug must carry under the Drugs Rules — generic and brand name, manufacturer, batch, licence number, and manufacturing and expiry dates. For the retailer, it means the medicine may only be dispensed against a prescription.

One point that often gets confused: being Schedule H does not, by itself, require a barcode or serialization for domestic sale. The domestic code requirement comes from Schedule H2, which applies to specific brands and categories. A Schedule H product needs a code because it's on the H2 list — not because it is Schedule H.

Schedule H1: Stricter Controls for Antibiotics and Habit-Forming Drugs

Schedule H1 was created in 2013 and took effect in March 2014, mainly to curb over-the-counter misuse of newer-generation antibiotics, anti-tuberculosis drugs and some habit-forming medicines — a direct response to concern about antimicrobial resistance. On the pack, H1 products carry the Rx symbol in red and a prominent boxed warning. At the pharmacy, the retailer must record each sale in a separate register, with the prescriber's name and address, the patient's name, and the drug and quantity supplied, and keep that register for three years.

Schedule X: The Tightest Controls

Schedule X covers drugs with significant abuse potential. The label carries the XRx symbol in red. The retailer must keep the prescription — written in duplicate — for two years, maintain separate records, and store the stock securely. Many Schedule X products are also controlled under the NDPS Act, 1985, which brings its own licensing and record-keeping obligations.

Schedule H2: The Code Requirement

Schedule H2 was added by G.S.R. 823(E) in November 2022 and works differently from the other schedules. It doesn't change who may sell a medicine or how. It requires the manufacturer to print or affix a Bar Code or QR Code on the label, carrying a unique product identification code, the proper and generic name, brand name, manufacturer's name and address, batch number, manufacturing and expiry dates, and manufacturing licence number.

Schedule H2 now has two tables:

In force since 1 August 2023
Table 1 — The Top 300 Brands
300 high-selling brand formulations named in the notification. Every batch manufactured on or after 1 August 2023 must carry the code, whether made in India or imported. The code goes on the primary pack label, or the secondary pack where the primary doesn't have enough space.
Notified 22 June 2026 · G.S.R. 506(E)
Table 2 — Whole Therapeutic Categories
All vaccines, all anticancer drugs, and all narcotic drugs and psychotropic substances under the NDPS Act come under the code requirement from 1 July 2027. All antimicrobials follow from 1 July 2028. Unlike Table 1, this isn't a list of brands — it covers every product in the category, which is a much larger number of SKUs.

When a Product Falls Under Two Schedules

Table 2 means overlap will soon be common. A third-generation antibiotic that is already Schedule H1 will also be in Schedule H2 from July 2028. Many NDPS drugs are Schedule X today and will be Schedule H2 from July 2027. For these products, the label has to carry both sets of requirements at once: the red Rx or XRx marking and boxed warning, and a scannable code with the H2 data set — often on a small primary pack that was never designed to hold both.

The schedules used to be a question for the pharmacist. With H2 expanding to whole categories, they're now a question for the artwork, the packaging line and the barcode system too. — Ratifye Regulatory Desk

What This Means for Packaging and Regulatory Teams

Where Ratifye Fits

Ratifye helps pharma brands meet the Schedule H2 requirement with GS1-compliant QR codes that carry the full prescribed data set — and goes a step further by making each pack's code unique and cryptographically signed, so a scan confirms that specific pack is genuine, not just that the batch exists. It runs on existing packaging lines without new hardware, and most teams go live in about two weeks — well ahead of the July 2027 deadline.

Take Action

Is your portfolio ready for Schedule H2 Table 2?

Ratifye's regulatory team can map your SKUs against Table 1 and Table 2 and show which products need codes, by when, and where on the pack. Start with 500 free authentications.

Talk to our regulatory team

Sources: Drugs Rules, 1945, including the provisions for Schedules G, H, H1 and X and the labelling rules; G.S.R. 588(E) of 2013 introducing Schedule H1; G.S.R. 823(E) dated 17 November 2022 inserting Schedule H2, and CDSCO FAQs on its implementation (July 2023); G.S.R. 506(E) dated 22 June 2026 (Drugs (Seventh Amendment) Rules, 2026) inserting Table 2 in Schedule H2; Narcotic Drugs and Psychotropic Substances Act, 1985. This article is a plain-language summary; consult the primary regulatory texts and legal counsel for compliance decisions.